CAS 53808-87-0|Tetroxoprim

Introduction:Basic information about CAS 53808-87-0|Tetroxoprim, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
Common NameTetroxoprim
CAS Number53808-87-0Molecular Weight334.37
Density1.232g/cm3Boiling Point564.1ºC at 760mmHg
Molecular FormulaC16H22N4O4Melting Point/
MSDS/Flash Point294.9ºC

Names

Name5-[[3,5-dimethoxy-4-(2-methoxyethoxy)phenyl]methyl]pyrimidine-2,4-diamine
SynonymMore Synonyms

Tetroxoprim BiologicalActivity

DescriptionTetroxoprim is an antimicrobial DHFR inhibitor[1].
Related CatalogResearch Areas >>InfectionSignaling Pathways >>Cell Cycle/DNA Damage >>AntifolateResearch Areas >>Inflammation/Immunology
In VitroTetroxoprim brings about a 50% in vitro inhibition with E. coli, at a concentration of 4 x 10-9M[1].
References

[1]. H S Aschhoff, et al. Tetroxoprim--a new inhibitor of bacterial dihydrofolate reductase. J Antimicrob Chemother. 1979 Nov;5(B):19-25.

Chemical & Physical Properties

Density1.232g/cm3
Boiling Point564.1ºC at 760mmHg
Molecular FormulaC16H22N4O4
Molecular Weight334.37
Flash Point294.9ºC
Exact Mass334.16400
PSA114.74000
LogP2.43660
Index of Refraction1.587
InChIKeyWSWJIZXMAUYHOE-UHFFFAOYSA-N
SMILESCOCCOc1c(OC)cc(Cc2cnc(N)nc2N)cc1OC

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
UV8190000
CHEMICAL NAME :
Pyrimidine, 2,4-diamino-5-(3,5-dimethoxy-4-(2-methoxyethoxy)benzy l)-
CAS REGISTRY NUMBER :
53808-87-0
BEILSTEIN REFERENCE NO. :
4271695
LAST UPDATED :
199612
DATA ITEMS CITED :
5
MOLECULAR FORMULA :
C16-H22-N4-O4
MOLECULAR WEIGHT :
334.42
WISWESSER LINE NOTATION :
T6N CNJ BZ DZ E1R CO1 EO1 DO2O1

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
1172 mg/kg
TOXIC EFFECTS :
Behavioral - somnolence (general depressed activity) Behavioral - convulsions or effect on seizure threshold Behavioral - muscle contraction or spasticity
REFERENCE :
DRFUD4 Drugs of the Future. (J.R. Prous, S.A., Apartado de Correos 540, 08080 Barcelona, Spain) V.1- 1975/76- Volume(issue)/page/year: 4,895,1979
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
300 mg/kg
TOXIC EFFECTS :
Behavioral - somnolence (general depressed activity) Behavioral - convulsions or effect on seizure threshold Behavioral - muscle contraction or spasticity
REFERENCE :
DRFUD4 Drugs of the Future. (J.R. Prous, S.A., Apartado de Correos 540, 08080 Barcelona, Spain) V.1- 1975/76- Volume(issue)/page/year: 4,895,1979
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
1060 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
JCHEEU Journal of Chemotherapy. (Edizioni Riviste Scientifiche, via R. Giuliani, 419, 50141 Florence, Italy) V.1- 1989- Volume(issue)/page/year: 5,400,1993
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
1410 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
JCHEEU Journal of Chemotherapy. (Edizioni Riviste Scientifiche, via R. Giuliani, 419, 50141 Florence, Italy) V.1- 1989- Volume(issue)/page/year: 5,400,1993
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
192 mg/kg
TOXIC EFFECTS :
Sense Organs and Special Senses (Eye) - ptosis Behavioral - somnolence (general depressed activity) Lungs, Thorax, or Respiration - cyanosis
REFERENCE :
DRFUD4 Drugs of the Future. (J.R. Prous, S.A., Apartado de Correos 540, 08080 Barcelona, Spain) V.1- 1975/76- Volume(issue)/page/year: 4,895,1979

Safety Information

Hazard CodesXi
HS Code2933599090

Customs

HS Code2933599090
Summary2933599090. other compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%

Synonyms

Tetroxoprima
Tetroxoprime [INN-French]
Tetroxoprimum [INN-Latin]
Tetroxoprime
Tetroxoprim
Tetroxoprimum
He 781
Tetroxoprima [INN-Spanish]
Tetroxoprima [Spanish]
CAS 22204-91-7|lifibrate
CAS 73514-87-1|fosarilate
Recommended......
TOP